Vaccines, Blood & Biologics
Influenza Virus Vaccine for the 2006-2007 Season
Influenza Vaccine Lot Release Status
This chart provides information on flu vaccine lots that have been released by FDA. This information will be updated periodically as additional vaccine is received from manufacturers and released by FDA.
For information on flu vaccine distribution schedules, please contact the manufacturers directly.
Lots Released as of December 13, 2006
|Manufacturer||Total Number of Lots Released by FDA|
Chiron Vaccines Ltd
Gaskill Road Speke,
Liverpool, L24 9GR, UK
Rue de l'Institut 89
B1330 Rixensart Belgium
ID Biomedical Corporation of Quebec (IDB)
MedImmune Vaccines, Inc
297 North Bernardo Ave
Mountain View, CA 94043
Sanofi Pasteur, Inc
Swiftwater, PA 18370
FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC) met in Bethesda, Maryland, on February 17, 2006, to select the influenza virus strains for the composition of the influenza vaccine for use in the 2006-2007 U.S. influenza season. During this meeting, the advisory panel reviewed and evaluated the surveillance data related to epidemiology and antigenic characteristics, serological responses to 2005/2006 vaccines, and the availability of candidate strains and reagents.
The panel recommended that vaccines to be used in the 2006-2007 season in the U.S. contain the following:
- an A/New Caledonia/20/99 (H1N1)-like virus;
- an A/Wisconsin/67/2005 (H3N2)-like virus (A/Wisconsin/67/2005 and A/Hiroshima/52/2005strains);
- a B/Malaysia/2506/2004-like virus (B/Malaysia/2506/2004 and B/Ohio/1/2005 strains)
The influenza vaccine composition to be used in the 2006-2007 season in the U.S. is identical to that recommended by the World Health Organization on February 15, 2006.